Comparison of mitochondrial and macrophage content between subcutaneous and visceral fat in db/db mice

Experimental and Molecular Pathology

Volumn 83, Issue 1, 2007, Pages 73-83

  Okamoto, Yuji ^a   Higashiyama, Hiroyuki ^a   Rong, James X ^b   McVey, Matthew J ^c   Kinoshita, Mine ^a   Asano, Satoshi ^a   Hansen, Michael K ^c  

^a Development and Medical Affairs Division   (Japan)

^b Discovery Technology   (Finland)

^c High Throughput Biology   (United States)

Author keywords

Diabetes; Macrophage; Mitochondrial biogenesis; Rosiglitazone; Subcutaneous adipose; Visceral adipose

Indexed keywords

HEAT SHOCK PROTEIN 60; ROSIGLITAZONE; UNCOUPLING PROTEIN 1;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL AGGREGATION; COMPARATIVE STUDY; CONTROLLED STUDY; DIABETES MELLITUS; EPIDIDYMIS FAT; INGUINAL REGION; INSULIN RESISTANCE; INTRAABDOMINAL FAT; MACROPHAGE; MALE; MITOCHONDRION; MOUSE; NONHUMAN; PROTEIN EXPRESSION; SUBCUTANEOUS FAT; WHITE ADIPOSE TISSUE;

ADIPOCYTES; ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; CELL COUNT; CELL SHAPE; CELL SIZE; CHAPERONIN 60; DIABETES MELLITUS; DISEASE MODELS, ANIMAL; INTRA-ABDOMINAL FAT; ION CHANNELS; MACROPHAGES; MALE; MICE; MITOCHONDRIA; MITOCHONDRIAL PROTEINS; SUBCUTANEOUS FAT; THIAZOLIDINEDIONES;

MUS;

EID: 34249733229     PISSN: 00144800     EISSN: 10960945     Source Type: Journal    
DOI: 10.1016/j.yexmp.2007.02.007     Document Type: Article

References (39)

1. Amrani A., Jafarian-Tehrani M., Mormede P., Durant S., Pleau J.M., Haour F., Dardenne M., and Homo-Delarche F. Interleukin-1 effect on glycemia in the non-obese diabetic mouse at the pre-diabetic stage. J. Endocrinol. 148 (1996) 139-148
2. Barzilai N., She L., Liu B.Q., Vuguin P., Cohen P., Wang J., and Rossetti L. Surgical removal of visceral fat reverses hepatic insulin resistance. Diabetes 48 (1999) 94-98
3. Bogacka I., Xie H., Bray G.A., and Smith S.R. Pioglitazone induces mitochondrial biogenesis in human subcutaneous adipose tissue in vivo. Diabetes 54 (2005) 1392-1399
4. Bruun J.M., Lihn A.S., Pedersen S.B., and Richelsen B. Monocyte chemoattractant protein-1 release is higher in visceral than subcutaneous human adipose tissue (AT): implication of macrophages resident in the AT. J. Clin. Endocrinol. Metab. 90 (2005) 2282-2289
5. Choo H.J., Kim J.H., Kwon O.B., Lee C.S., Mun J.Y., Han S.S., Yoon Y.S., Yoon G., Choi K.M., and Ko Y.G. Mitochondria are impaired in the adipocytes of type 2 diabetic mice. Diabetologia 49 (2006) 784-791
6. Cinti S. The adipose organ. Prostaglandins Leukot. Essent. Fat. Acids 73 (2005) 9-15
7. Cote M., Mauriege P., Bergeron J., Almeras N., Tremblay A., Lemieux I., and Despres J.P. Adiponectinemia in visceral obesity: impact on glucose tolerance and plasma lipoprotein and lipid levels in men. J. Clin. Endocrinol. Metab. 90 (2005) 1434-1439
8. Gesta S., Bluher M., Yamamoto Y., Norris A.W., Berndt J., Kralisch S., Boucher J., Lewis C., and Kahn C.R. Evidence for a role of developmental genes in the origin of obesity and body fat distribution. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 6676-6681
9. Giusti V., Suter M., Verdumo C., Gaillard R.C., Burckhardt P., and Pralong F.P. Molecular determinants of human adipose tissue: differences between visceral and subcutaneous compartments in obese women. J. Clin. Endocrinol. Metab. 89 (2004) 1379-1384
10. Grimble R.F. Inflammatory status and insulin resistance. Curr. Opin. Clin. Nutr. Metab. Care 5 (2002) 551-559
11. Hotamisligil G.S., and Spiegelman B.M. Tumor necrosis factor alpha: a key component of the obesity-diabetes link. Diabetes 43 (1994) 1271-1278
12. Hotamisligil G.S., Murray D.L., Choy L.N., and Spiegelman B.M. Tumor necrosis factor alpha inhibits signaling from the insulin receptor. Proc. Natl. Acad. Sci. U. S. A. 91 (1994) 4854-4858
13. Hotamisligil G.S., Shargill N.S., and Spiegelman B.M. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 259 (1993) 87-91
14. Hrnciar J., Gabor D., Hrnciarova M., Okapcova J., Szentivanyi M., and Kurray P. Relation between cytokines (TNF-alpha, IL-1 and 6) and homocysteine in android obesity and the phenomenon of insulin resistance syndromes. Vnitr. Lek. 45 (1999) 11-16
15. Jernas M., Palming J., Sjoholm K., Jennische E., Svensson P.A., Gabrielsson B.G., Levin M., Sjogren A., Rudemo M., Lystig T.C., Carlsson B., Carlsson L.M.S., and Lonn M. Separation of human adipocytes by size: hypertrophic fat cells display distinct gene expression. FASEB J. 20 9 (2006) NIL_271-NIL_278
16. Kuk J.L., Church T.S., Blair S.N., and Ross R. Does measurement site for visceral and abdominal subcutaneous adipose tissue alter associations with the metabolic syndrome?. Diabetes Care 29 (2006) 679-684
17. Li Y., Bujo H., Takahashi K., Shibasaki M., Zhu Y., Yoshida Y., Otsuka Y., Hashimoto N., and Saito Y. Visceral fat: higher responsiveness of fat mass and gene expression to calorie restriction than subcutaneous fat. Exp. Biol. Med. (Maywood) 228 (2003) 1118-1123
18. Lin J., Handschin C., and Spiegelman B.M. Metabolic control through the PGC-1 family of transcription coactivators. Cell Metab. 1 (2005) 361-370
19. Lundgren M., Buren J., Ruge T., Myrnas T., and Eriksson J.W. Glucocorticoids down-regulate glucose uptake capacity and insulin-signaling proteins in omental but not subcutaneous human adipocytes. J. Clin. Endocrinol. Metab. 89 (2004) 2989-2997
20. Macor C., Ruggeri A., Mazzonetto P., Federspil G., Cobelli C., and Vettor R. Visceral adipose tissue impairs insulin secretion and insulin sensitivity but not energy expenditure in obesity. Metabolism 46 (1997) 123-129
21. Maffei M., Fei H., Lee G.H., Dani C., Leroy P., Zhang Y., Proenca R., Negrel R., Ailhaud G., and Friedman J.M. Increased expression in adipocytes of ob RNA in mice with lesions of the hypothalamus and with mutations at the db locus. Proc. Natl. Acad. Sci. U. S. A. 92 (1995) 6957-6960
22. Milan G., Granzotto M., Scarda A., Calcagno A., Pagano C., Federspil G., and Vettor R. Resistin and adiponectin expression in visceral fat of obese rats: effect of weight loss. Obes. Res. 10 (2002) 1095-1103
23. Misra A., and Vikram N.K. Clinical and pathophysiological consequences of abdominal adiposity and abdominal adipose tissue depots. Nutrition 19 (2003) 457-466
24. Okuno A., Tamemoto H., Tobe K., Ueki K., Mori Y., Iwamoto K., Umesono K., Akanuma Y., Fujiwara T., Horikoshi H., Yazaki Y., and Kadowaki T. Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats. J. Clin. Invest. 101 (1998) 1354-1361
25. Orci L., Cook W.S., Ravazzola M., Wang M.Y., Park B.H., Montesano R., and Unger R.H. Rapid transformation of white adipocytes into fat-oxidizing machines. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 2058-2063
26. Pedersen O., Kahn C.R., and Kahn B.B. Divergent regulation of the Glut 1 and Glut 4 glucose transporters in isolated adipocytes from Zucker rats. J. Clin. Invest. 89 (1992) 1964-1973
27. Powelka A.M., Seth A., Virbasius J.V., Kiskinis E., Nicoloro S.M., Guilherme A., Tang X., Straubhaar J., Cherniack A.D., Parker M.G., and Czech M.P. Suppression of oxidative metabolism and mitochondrial biogenesis by the transcriptional corepressor RIP140 in mouse adipocytes. J. Clin. Invest. 116 (2006) 125-136
28. Robidoux J., Martin T.L., and Collins S. Beta-adrenergic receptors and regulation of energy expenditure: a family affair. Annu. Rev. Pharmacol. Toxicol. 44 (2004) 297-323
29. Sartipy P., and Loskutoff D.J. Monocyte chemoattractant protein 1 in obesity and insulin resistance. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 7265-7270
30. Sartipy P., and Loskutoff D.J. Expression profiling identifies genes that continue to respond to insulin in adipocytes made insulin-resistant by treatment with tumor necrosis factor-alpha. J. Biol. Chem. 278 52 (2003) 52298-52306
31. Schwartz M.W., and Kahn S.E. Insulin resistance and obesity. Nature 402 (1999) 860-861
32. Skurk T., Alberti-Huber C., Herder C., and Hauner H. Relationship between adipocyte size and adipokine expression and secretion. J. Clin. Endocrinol. Metab. (2006) Rapid Electronic Publication first published on Dec 12, 2006 as doi:10.1210/jc.2006-1055
33. Um S.H., Frigerio F., Watanabe M., Picard F., Joaquin M., Sticker M., Fumagalli S., Allegrini P.R., Kozma S.C., Auwerx J., and Thomas G. Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity. Nature 431 (2004) 200-205
34. Uysal K.T., Wiesbrock S.M., and Hotamisligil G.S. Functional analysis of tumor necrosis factor (TNF) receptors in TNF-alpha-mediated insulin resistance in genetic obesity. Endocrinology 139 (1998) 4832-4838
35. Wajchenberg B.L. Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocr. Rev. 21 (20006) 97-738
36. Weisberg S.P., McCann D., Desai M., Rosenbaum M., Leibel R.L., and Ferrante Jr. A.W. Obesity is associated with macrophage accumulation in adipose tissue. J. Clin. Invest. 112 (2003) 1796-1808
37. Wilson-Fritch L., Nicoloro S., Chouinard M., Lazar M.A., Chui P.C., Leszyk J., Straubhaar J., Czech M.P., and Corvera S. Mitochondrial remodeling in adipose tissue associated with obesity and treatment with rosiglitazone. J. Clin. Invest. 114 (2004) 1281-1289
38. Xu H., Barnes G.T., Yang Q., Tan G., Yang D., Chou C.J., Sole J., Nichols A., Ross J.S., Tartaglia L.A., and Chen H. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J. Clin. Invest. 112 (2003) 1821-1830
39. Yamauchi T., Waki H., Kamon J., Murakami K., Motojima K., Komeda K., Miki H., Kubota N., Terauchi Y., Tsuchida A., Tsuboyama-Kasaoka N., Yamauchi N., Ide T., Hori W., Kato S., Fukayama M., Akanuma Y., Ezaki O., Itai A., Nagai R., Kimura S., Tobe K., Kagechika H., Shudo K., and Kadowaki T. Inhibition of RXR and PPARgamma ameliorates diet-induced obesity and type 2 diabetes. J. Clin. Invest. 108 (2001) 1001-1013